0001615219-22-000018.txt : 20220309 0001615219-22-000018.hdr.sgml : 20220309 20220309160155 ACCESSION NUMBER: 0001615219-22-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220303 FILED AS OF DATE: 20220309 DATE AS OF CHANGE: 20220309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arthur David J. CENTRAL INDEX KEY: 0001769331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36812 FILM NUMBER: 22725356 MAIL ADDRESS: STREET 1: 2450 HOLCOME BLVD. STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 346-772-0346 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: Flex Pharma, Inc. DATE OF NAME CHANGE: 20140730 4 1 wf-form4_164685969931166.xml FORM 4 X0306 4 2022-03-03 0 0001615219 Salarius Pharmaceuticals, Inc. SLRX 0001769331 Arthur David J. C/O SALARIUS PHARMACEUTICALS, INC. 2450 HOLCOME BLVD., SUITE X HOUSTON TX 77021 1 1 0 0 Chief Executive Officer Common Stock 2022-03-03 4 P 0 139488 0.391 A 249674 D The Registrant issued these shares to the reporting person as part of his bonus; which shares were issued in lieu of net cash compensation. The shares were issued at the fair market value of the Registrants common stock on the date of grant. /s/Mark Rosenblum, as Attorney-in-Fact 2022-03-09